← Back to Search

Repetitive Transcranial Magnetic Stimulation

Intermittent Theta Burst Stimulation (form of repetitive transcranial magnetic stimulation) given in an accelerated form for Major Depressive Disorder

N/A

Waitlist Available

Led By Robyn Waxman

Research Sponsored by Ontario Shores Centre for Mental Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up during and after each rtms treatment during acute treatment and up to a week after treatment

Awards & highlights

Study Summary

This trial will assess the feasibility and clinical outcomes of a high-dose iTBS protocol for patients with major depressive disorder who are waiting for ECT or rTMS.

Eligible Conditions

Major Depressive Disorder

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at screening (within a week of starting treatment) to a week post treatment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at screening (within a week of starting treatment) to a week post treatment

This trial's timeline: 3 weeks for screening, Varies for treatment, and at screening (within a week of starting treatment) to a week post treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Remission of depressive symptoms using the Hamilton Depression Rating Scale (HAM - D or HDRS) - 17 version

Secondary outcome measures

Change in World Health Organization Disability assessment scale (WHODAS)

Change in the Quality of Life, Enjoyment, and Satisfaction Questionnaire (QUAL-ES-Q)

Improvement overall using the Clinical Global Severity/Impression Scale (CGI-I)

+3 more

Other outcome measures

Adverse effects of the treatment

Trial Design

1Treatment groups

Experimental Treatment

Group I: Patients receiving accelerated rTMSExperimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Intermittent Theta Burst Stimulation (form of repetitive transcranial magnetic stimulation) given in an accelerated form

2022

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Ontario Shores Centre for Mental Health SciencesLead Sponsor

12 Previous Clinical Trials

2,114 Total Patients Enrolled

Robyn WaxmanPrincipal InvestigatorOntario Shores

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What upper limit of participants has been set for this clinical experiment?

"Affirmative. The clinicaltrials.gov listing reveals that this medical research, initially published on December 1st 2022, is presently enrolling participants. 24 volunteers are needed to be admitted from a single site."

Answered by AI

Are there still spots available to join this clinical trial?

"Affirmative. According to the clinicaltrials.gov platform, this medical trial is actively enrolling suitable candidates and was recently refreshed on 1/12/2022. 24 participants are needed in total from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Accelerated Intermittent Theta Burst Stimulation for Depressed Patients During the Covid-19 Pandemic

Dr. Robyn Waxman 2022. "Accelerated Intermittent Theta Burst Stimulation for Depressed Patients During the Covid-19 Pandemic". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04935489.